News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

AvidBiotics Awarded SBIR Grant for Avidocin™ Antibacterial Proteins Against Clostridium difficile


10/1/2012 10:11:20 AM

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--AvidBiotics Corp. today announced the receipt of grant from the National Institute of Allergic and Infectious Diseases of the National Institutes of Health to further development of the company’s targetable bactericidal proteins to specifically kill Clostridium difficile bacteria. The new Small Business Innovation Research (SBIR) grant, Award Number R43AI098186, provides AvidBiotics with a total of $600,000 of research funding over two years.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES